产品说明书

Tropicamide

Print
Chemical Structure| 1508-75-4 同义名 : Ro 1-7683
CAS号 : 1508-75-4
货号 : A130661
分子式 : C17H20N2O2
纯度 : 98%
分子量 : 284.353
MDL号 : MFCD00058580
存储条件:

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 25 mg/mL(87.92 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
靶点
  • mAChR

    M4 mAChR, IC50:8 nM

描述 Tropicamide is an anticholinergic and a muscarinic receptor subtype M4-preferring antagonist. Tropicamide causes a more rapid return of near vision and a lesser stinging sensation relative to cyclopentolate. And Tropicamide requires a shorter duration to obtain maximum cycloplegia, and rarely induces systemic side effects[3]. Moreover, the mixture containing 0.75% tropicamide and 2.5% phenylephrine was effective in pupil dilatation. It provided rapid and successful pupil dilatation for ophthalmoscopy, more than the alternate application of 1% tropicamide and 10% phenylephrine[4].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02124486 Idiopathic Intracranial Hypert... 展开 >>ension 收起 << Not Applicable Active, not recruiting August 2, 2022 United Kingdom ... 展开 >> University Hospital Birmingham (Queen Elizabeth Hospital) Birmingham, West Midlands, United Kingdom, B15 2TH 收起 <<
NCT00817063 Eczema Phase 3 Completed - -
NCT00227253 - Recruiting December 2025 United States, Texas ... 展开 >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Jannine D Cody, Ph.D.    210-567-9220    cody@uthscsa.edu    Contact: Daniel E Hale, M.D.    210-567-5284    hale@uthscsa.edu    Principal Investigator: Jannine D. Cody, Ph.D.          Sub-Investigator: Peter T. Fox, M.D.          Principal Investigator: Daniel E. Hale, M.D.          Sub-Investigator: Brian P Perry, M.D. 收起 <<
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.58mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

参考文献

[1]Selk Ghaffari M, Javadzadeh R, Rajaei SM. Effects of two concentrations of topical tropicamide on the Schirmer tear test in clinically normal cats. J Feline Med Surg. 2016 Dec;18(12):965-969.

[2]Bersani FS, Imperatori C, et al. Injecting eye-drops: a mini-review on the non-clinical use of tropicamide. Hum Psychopharmacol. 2015 Jul;30(4):262-4.

[3]Yoo SG, Cho MJ, Kim US, Baek SH. Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen. Korean J Ophthalmol. 2017 Jun;31(3):249-256. doi: 10.3341/kjo.2016.0007. Epub 2017 Apr 24. PMID: 28471102; PMCID: PMC5469928.

[4]Trinavarat A, Pituksung A. Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial. Indian J Ophthalmol. 2009 Sep-Oct;57(5):351-4. doi: 10.4103/0301-4738.55070. PMID: 19700872; PMCID: PMC2804122.